Advertisement
Salesforce
Salesforce

The Scientist

» NIH

Most Recent

image: H5N1 Moratorium Extended

H5N1 Moratorium Extended

By | August 2, 2012

The head of a US infectious disease funding body urges researchers to continue the voluntary cessation of research on avian influenza.

0 Comments

image: Stem Cell Trickery

Stem Cell Trickery

By | July 9, 2012

A postdoctoral research fellow at Emory University falsifies stem cell research data.

8 Comments

image: Alternative Medicines

Alternative Medicines

By | July 1, 2012

As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.

64 Comments

image: Obamacare Will Affect Research

Obamacare Will Affect Research

By | June 29, 2012

The Supreme Court's decision to uphold President Barack Obama's health care reform law contains key provisions that will impact US science funding in the years to come.

28 Comments

image: NIH Tackles Racism

NIH Tackles Racism

By | June 25, 2012

An advisory committee urges the federal funding agency to take steps to counter racial bias in the granting process.

2 Comments

image: FDA Disputes Data Under-Reporting

FDA Disputes Data Under-Reporting

By | May 2, 2012

The FDA and NIH dispute reports that clinical trial data is being under-reported.

0 Comments

image: More Research Money for MDs

More Research Money for MDs

By | May 1, 2012

Principal investigators with medical training have a slightly higher NIH funding rate than those with just a PhD.

6 Comments

image: An NIH Director Departs

An NIH Director Departs

By | April 26, 2012

The newly appointed chief of one Institute gives up his appointment days before starting.

0 Comments

image: Stem Cell Researcher Fabricates Data

Stem Cell Researcher Fabricates Data

By | April 16, 2012

A scientist who claimed to have injected monkey embryonic stem cells into the eyes of rats to improve their vision accepts the penalty for research misconduct.

8 Comments

image: Repurpose Failed Drugs, NIH Urges

Repurpose Failed Drugs, NIH Urges

By | April 16, 2012

Francis Collins says pharmaceutical companies should help bridge the gap between basic science and applications with old drug compounds.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
The Scientist
The Scientist

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
The Scientist
The Scientist
Advertisement
NeuroScientistNews
NeuroScientistNews
Life Technologies